115 related articles for article (PubMed ID: 2987620)
1. Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV).
De Vecchis L; Graziani G; Macchi B; Grandori C; Pastore S; Popovic M; Gallo RC; Bonmassar E
Leuk Res; 1985; 9(3):349-55. PubMed ID: 2987620
[TBL] [Abstract][Full Text] [Related]
2. Lysis of human T cell leukemia virus infected T and B lymphoid cells by interleukin 2-activated killer cells.
Froelich CJ; Guiffaut S
J Immunol; 1987 Dec; 139(11):3637-43. PubMed ID: 2824611
[TBL] [Abstract][Full Text] [Related]
3. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus.
Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y
Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403
[TBL] [Abstract][Full Text] [Related]
4. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
5. A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I).
Tanaka Y; Inoi T; Tozawa H; Yamamoto N; Hinuma Y
Int J Cancer; 1985 Nov; 36(5):549-55. PubMed ID: 2997042
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibody-dependent cellular cytotoxicity against human T-cell leukemia/lymphoma virus (HTLV)-producing cells.
Miyakoshi H; Koide H; Aoki T
Int J Cancer; 1984 Mar; 33(3):287-91. PubMed ID: 6321358
[TBL] [Abstract][Full Text] [Related]
7. Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses.
Aoki T; Hamada C; Ohno S; Miyakoshi H; Kaneko Y; Robert-Guroff M; Ting RC; Gallo RC
Haematol Blood Transfus; 1985; 29():342-4. PubMed ID: 2993130
[No Abstract] [Full Text] [Related]
8. HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells.
Franchini G; Mann DL; Popovic M; Zicht RR; Gallo RC; Wong-Staal F
Leuk Res; 1985; 9(11):1305-14. PubMed ID: 3001435
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection.
Macchi B; Popovic M; Allavena P; Ortaldo J; Rossi P; Gallo RC; Bonmassar E
Int J Cancer; 1987 Jul; 40(1):1-6. PubMed ID: 2885278
[TBL] [Abstract][Full Text] [Related]
10. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytes.
Moore JL; Poiesz BJ; Zamkoff KW; Merl SA; Hanna S; Gazdar AF; Comis RL
J Virol; 1985 Feb; 53(2):440-6. PubMed ID: 2982030
[TBL] [Abstract][Full Text] [Related]
12. Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers.
Tochikura T; Iwahashi M; Matsumoto T; Koyanagi Y; Hinuma Y; Yamamoto N
Int J Cancer; 1985 Jul; 36(1):1-7. PubMed ID: 2862107
[TBL] [Abstract][Full Text] [Related]
13. Experimental infection of rabbits with human T-cell leukemia virus type I.
Akagi T; Takeda I; Oka T; Ohtsuki Y; Yano S; Miyoshi I
Jpn J Cancer Res; 1985 Feb; 76(2):86-94. PubMed ID: 2984072
[TBL] [Abstract][Full Text] [Related]
14. Low concentrations of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture.
Pesce CD; Ciprani F; D'Onofrio C; Alvino E; Perno CF; Bonmassar E; Caliò R
Antiviral Res; 1987 Dec; 8(5-6):247-60. PubMed ID: 2897831
[TBL] [Abstract][Full Text] [Related]
15. Natural killer activity from normal peripheral blood lymphocytes against a human T lymphotropic retrovirus type III (HTLV-III)-infected cell line.
Sirianni MC; De Sanctis G; Macchi B; Soddu S; Ensoli F; Aiuti F; Fontana L
Diagn Clin Immunol; 1988; 5(6):297-303. PubMed ID: 3219779
[TBL] [Abstract][Full Text] [Related]
16. Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro.
Graziani G; Pasqualetti D; Lopez M; D'Onofrio C; Testi AM; Mandelli F; Gallo RC; Bonmassar E
Blood; 1987 Apr; 69(4):1175-81. PubMed ID: 2881587
[TBL] [Abstract][Full Text] [Related]
17. Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.
D'Onofrio C; Perno CF; Mazzetti P; Graziani G; Calio' R; Bonmassar E
Br J Cancer; 1988 May; 57(5):481-8. PubMed ID: 2899440
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of cytotoxicity induced by HTLV-I carrying cells against a human lymphoblastoid cell line, Molt-4.
Kikukawa-Itamura R; Harada S; Kobayashi N; Hatanaka M; Yamamoto N
Leuk Res; 1987; 11(4):331-8. PubMed ID: 2882068
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of human leukocytes by staphylococcal enterotoxin A: augmentation of natural killer cells and induction of suppressor cells.
Platsoucas CD; Oleszak EL; Good RA
Cell Immunol; 1986 Feb; 97(2):371-85. PubMed ID: 2943428
[TBL] [Abstract][Full Text] [Related]
20. Killer cell systems of cynomolgus monkeys experimentally infected with HTLV-1.
Yoshimura N; Nakamura H; Honjo S; Akiyama N; Hayami M
J Immunol; 1988 Sep; 141(6):1970-4. PubMed ID: 2459198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
